NCT02641925

Omentectomy for Metabolic Syndrome in Gastric Cancer Patients

The Effect of Visceral Fat Removal for Gastric Cancer Patients With Metabolic Syndrome, Randomized Pilot Study: Omentectomy for Metabolic Syndrome (OMS)

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Keimyung University Dongsan Medical Center · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Many features of the metabolic syndrome are associated with insulin resistance. And, metabolic syndrome and insulin resistance are related to visceral obesity. Therefore, the investigators hypothesized that visceral fat removal (omentectomy) can make favorable results for the insulin resistance and metabolic syndrome. As the omentectomy is optional procedure during a surgery for early gastric cancer, the investigators will divide patients randomly into two groups, total omentectomy group and omentum preserving group.

Detailed description

The investigators will compare the change of insulin resistance (HOMA-IR) and improvement of metabolic syndrome between total omentectomy and omentum preserving group.

Conditions

• Metabolic Syndrome
• Gastric Cancer

Interventions

Type	Name	Description
PROCEDURE	Omentum preserving	The minimum volume of omentum (within 3cm from gastroepiploic vessel) will be removed during gastrectomy with lymph node dissection.
PROCEDURE	Total omentectomy	Whole omentum will be removed during gastrectomy with lymph node dissection.

Timeline

• Start date: 2015-08-01
• Primary completion: 2019-08-01
• Completion: 2020-08-01
• First posted: 2015-12-30
• Last updated: 2017-06-01

Locations

3 sites across 1 country: South Korea